
Hemolab Pharma provides essential hospital and specialty medications, focusing on injectable presentations. Established in 1996 to meet the needs of nephrologists, Hemolab Pharma specializes in the production of hemodialysis concentrates and the distribution of vital medications. Hemolab Pharma is a partner of international actors, notably French and Spanish, and continues its development by investing in medications with significant medical benefits.
Annual Revenue$50M to $100M
Estimated OwnershipPrivateBuilt from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Matching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.